Calendar Adaptimmune Therapeutics plc

Equities

ADAP

US00653A1079

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.075 USD +1.42% Intraday chart for Adaptimmune Therapeutics plc +10.06% +35.56%

Chart calendar Adaptimmune Therapeutics plc

d324940890ffa47a90411.NE5zstn2UFjyt45-GU94uBB98qa3z5fbT7gj_GChOCU.Wh4H5YGTGje21rg9bHcejGUyuMzwhdSpDOBIvw30cGd3CRXXu6kWDKjo5Q~b41c0068fd4defb64263bdba72cf8517

Upcoming events on Adaptimmune Therapeutics plc

2024-05-05 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)

Past events on Adaptimmune Therapeutics plc

2024-04-18 09:30 am Investor Day
2024-04-08 08:00 am Needham Virtual Healthcare Conference
2024-03-25 H.C. Wainwright Cell Therapy Virtual Conference
2024-03-12 01:40 pm Leerink Partners Global Biopharma Conference
2024-03-06 08:00 am Q4 2023 Earnings Call
2024-03-06 07:00 am Q4 2023 Earnings Release
2024-03-04 10:30 am TD Cowen Health Care Conference
2024-02-08 01:30 pm Guggenheim Healthcare Talks Biotechnology Conference
2024-01-11 11:15 am JPMorgan Healthcare Conference
2023-11-08 08:00 am Q3 2023 Earnings Call
2023-11-08 07:30 am Q3 2023 Earnings Release
2023-09-27 08:35 am Cantor Global Healthcare Conference
2023-08-09 08:00 am Q2 2023 Earnings Call
2023-08-09 07:29 am Q2 2023 Earnings Release
2023-06-03 02:15 pm American Society of Clinical Oncology Conference
2023-06-02 08:00 am Business Update Call
2023-05-16 07:00 am Annual General Meeting
2023-05-12 08:00 am Q1 2023 Earnings Call
2023-05-12 07:29 am Q1 2023 Earnings Release
2023-04-17 09:30 am American Association for Cancer Research Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
1,12
1,92
-41.56%
3,96
3,29
20.18%
6,15
111
-94.44%
27,1
25,5
6.63%
60,3
86,1
-29.95%

87,8

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
-158
-170
6.96%
-130
-81,7
-59%

-63,3

EBIT
Million USD
Released
Forecast
Spread
-140
-145
3.77%
-133
-132
-0.96%
-162
-159
-2.04%
-164
-172
4.53%
-140
-105
-33.04%

-86,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-137
-146
6.26%
-130
-129
-0.91%
-157
-156
-0.64%
-163
-160
-2.15%
-113
-74,3
-51.53%

-81,2

Net income
Million USD
Released
Forecast
Spread
-137
-146
6.24%
-130
-129
-0.96%
-158
-82,7
-91.16%
-165
-165
-0.41%
-114
-83,2
-36.95%

-88,2

EPS
USD
Released
Forecast
Spread
-1,32
-1,35
2.22%
-0,90
-0,90
0.37%
-1,02
-0,52
-96.15%
-1,02
-1,07
4.67%
-0,54
-0,33
-63.64%

-0,37

Announcement Date27/02/2025/02/2114/03/2206/03/2306/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
1,42
106
-98.66%
3,58
5,00
-28.5%
5,54
10,1
-45.17%
7,01
5,00
40.14%
11,0
5,08
116.94%
47,6


5,13
6,68
-23.15%
7,32
15,1
-51.66%
0,23
26,0
-99.11%

20,5


25,7


14,9


26,8


15,9

EBIT
Million USD
Released
Forecast
Spread
-42,9
-39,6
-8.24%
-50,0
-42,5
-17.69%
-43,8
-49,0
10.71%
-43,0
-45,2
4.95%
-27,2
-42,1
35.29%
1,66


-44,9
-42,4
-5.83%
-46,6
-30,2
-54.26%
-49,9
-15,1
-229.3%

-23,6


-16,6


-29,7


-17,1


-32,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-38,6
-37,6
-2.79%
-49,6
-39,7
-25.02%
-44,1
-49,0
10.1%
-41,0
-38,9
-5.46%
-28,3
-38,0
25.64%
1,66


-20,7
-47,6
56.49%
-44,9
-29,0
-54.88%
-48,6
-10,3
-370.06%

-22,1


-15,4


-28,2


-15,5


-32,3

Net income
Million USD
Released
Forecast
Spread
-38,9
36,5
-206.46%
-50,3
-39,8
-26.29%
-44,5
-41,4
-7.67%
-41,4
-38,9
-6.48%
-29,3
-38,0
23.03%
1,04


-21,4
-47,9
55.35%
-45,6
-32,0
-42.39%
-47,9
-17,2
-178.59%

-23,4


-18,2


-28,6


-18,1


-32,3

EPS
USD
Released
Forecast
Spread
-0,24
0,25
-197.96%
-0,30
-0,25
-22.45%
-0,05
-0,26
80.77%
-0,04
-0,24
83.33%
-0,18
-0,23
20%
0,00
-0,14
-
-0,12
-0,21
42.86%
-0,03
-0,19
83.93%
-0,24
0,00
-

-0,08


-0,09


-0,10


-0,09


-0,14

Announcement Date14/03/2209/05/2204/08/2208/11/2206/03/2312/05/2309/08/2308/11/2306/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ADAP Stock
  4. Calendar Adaptimmune Therapeutics plc